african
american
individu
disproportion
affect
asthma
morbid
mortal
socioeconom
factor
alon
complet
account
dispar
viral
ill
particularli
rhinoviru
consid
frequent
trigger
asthma
exacerb
previou
studi
shown
genet
predictor
asthma
may
differ
african
american
white
individu
stand
reason
predictor
asthma
exacerb
may
also
differ
raceethn
evalu
whether
singl
nucleotid
polymorph
snp
gene
thought
modul
innat
immun
respons
respiratori
virus
primarili
rigi
pathway
baff
relat
gene
associ
exacerb
among
african
american
individu
asthma
baff
polymorph
associ
asthma
exacerb
serum
baff
level
baff
express
vivo
increas
natur
rhinoviru
infect
baff
may
play
role
airway
antivir
immun
impact
asthma
exacerb
rate
baff
bcell
activ
factor
tumor
necrosi
factor
ligand
superfamili
asthma
asthma
exacerb
genet
african
american
individu
disproportion
affect
asthma
morbid
mortal
socioeconom
factor
alon
complet
account
dispar
viral
ill
particularli
rhinoviru
consid
frequent
trigger
asthma
exacerb
previou
studi
shown
genet
predictor
asthma
may
differ
african
american
white
individu
stand
reason
predictor
asthma
exacerb
may
also
differ
raceethn
evalu
whether
singl
nucleotid
polymorph
snp
gene
thought
modul
innat
immun
respons
respiratori
virus
primarili
rigi
pathway
baff
relat
gene
associ
exacerb
among
african
american
individu
asthma
complet
method
outlin
onlin
supplement
selfidentifi
african
american
particip
asthma
three
independ
studi
cohort
includ
analysi
includ
discoveri
cohort
chicago
initi
rais
asthma
health
equiti
chirah
studi
two
replic
cohort
studi
african
american
asthma
gene
environ
sage
studi
asthma
phenotyp
pharmacogenom
interact
raceethn
sapphir
tabl
subset
unrel
african
american
subject
sapphir
studi
also
provid
serum
determin
level
baff
elisa
kit
specif
recogn
baff
r
system
minneapoli
mn
assess
whether
rhinoviru
induc
baff
express
airway
vivo
util
sampl
separ
studi
common
cold
asthmat
adult
evalu
within
day
onset
rhinoviru
upper
respiratori
tract
infect
proven
virochip
nasal
lavag
asymptomat
baselin
ie
least
day
follow
cold
symptom
onset
baff
mrna
quantifi
nasal
mucos
sampl
quantit
realtim
rtpcr
use
multivari
neg
binomi
regress
assess
relationship
genotyp
risk
exacerb
cohort
sapphir
cox
proport
hazard
model
also
use
assess
relationship
genotyp
time
exacerb
analysi
varianc
use
assess
differ
mean
serum
level
baff
genotyp
analys
rv
induc
baff
express
vivo
compar
level
point
acut
ill
day
onset
uri
baselin
level
day
onset
uri
use
wilcoxon
sign
rank
sum
test
nonparametr
data
analys
perform
use
sa
sa
institut
inc
cari
nc
gene
evalu
see
tabl
baff
intron
snp
near
criterion
nomin
level
signific
discoveri
cohort
meet
bonferroni
level
signific
snp
type
within
gene
rel
rate
rr
borderlin
protect
find
chirah
cohort
contrast
associ
observ
two
cohort
tabl
specif
minor
allel
snp
associ
increas
exacerb
rate
sage
rr
sapphir
allel
also
associ
increas
ed
visit
rr
oral
steroid
cours
rr
overal
exacerb
rate
rr
similarli
sapphir
allel
associ
shorter
time
oral
steroid
prescript
hazard
ratio
hr
ed
visit
hr
well
exacerb
overal
hr
random
subset
sapphir
studi
particip
serum
level
baff
vari
baff
genotyp
onlin
figur
aa
ag
genotyp
higher
level
gg
homozyg
wild
type
genotyp
pgml
standard
deviat
sd
pgml
sd
pgml
sd
jonckheereterpstra
test
trend
separ
sampl
adult
asthmat
communityacquir
upper
respiratori
tract
infect
copi
number
baff
mrna
almost
five
fold
higher
nasal
epitheli
cell
sampl
taken
time
activ
rhinoviru
upper
respiratori
tract
infect
ie
day
onset
symptom
mean
gene
copi
number
compar
postconvalesc
baselin
sampl
ie
least
week
symptom
onset
mean
gene
copi
number
p
wilcoxon
sign
rank
test
figur
similarli
nasal
lavag
sampl
assay
baff
protein
show
baff
inde
induc
natur
rhinoviru
infect
subject
figur
pgml
compar
post
convalesc
sampl
pgml
mann
whitney
test
summari
intron
snp
baff
gene
allel
associ
asthma
exacerb
two
african
american
asthmat
cohort
time
first
exacerb
higher
serum
level
baff
baff
also
upregul
respons
commun
acquir
rhinoviru
infect
common
viral
infect
associ
exacerb
children
adult
baff
shown
induc
virus
present
elev
level
airway
epithelium
children
rsv
abil
local
tissu
mount
rapid
effect
local
immunoglobulin
respons
virus
like
import
limit
extent
sever
virusinduc
tissu
damag
group
previous
shown
dsrna
ligand
activ
produc
rsv
rhinoviru
potent
effect
induc
baff
product
airway
epitheli
cell
express
baff
regul
signal
hypothes
higher
serum
level
baff
associ
aggress
immun
respons
viru
may
particularli
import
sinc
interact
innat
adapt
immun
respons
may
provok
asthma
exacerb
studi
limit
name
subject
chirah
minor
allel
allel
relationship
cohort
opposit
direct
two
cohort
therefor
find
chirah
may
spuriou
nevertheless
allel
consist
robustli
associ
asthma
exacerb
sapphir
sage
given
low
frequenc
allel
evalu
influenc
genotyp
baff
induct
rhinoviru
studi
need
conclus
evalu
polymorph
viral
respons
gene
found
intron
snp
baff
gene
associ
asthma
exacerb
african
american
subject
two
three
cohort
patient
snp
also
associ
higher
level
baff
compar
individu
homozyg
g
allel
given
import
asthma
exacerb
minor
urban
popul
studi
need
determin
genet
environment
contributor
complex
outcom
figur
display
rtpcr
result
baff
gene
copi
number
natur
acquir
infect
yaxi
repres
baff
gene
copi
number
xaxi
repres
time
sampl
day
cold
onset
figur
display
concentr
baff
protein
nasal
lavag
fluid
natur
acquir
infect
yaxi
repres
baff
concentr
pgml
xaxi
repres
time
sampl
day
cold
onset
analys
sage
adjust
patient
age
sex
african
ancestri
estim
socioeconom
statu
base
geocod
home
address
current
smoke
statu
passiv
smoke
exposur
total
serum
ige
level
use
inhal
corticosteroid
analys
sapphir
adjust
age
sex
african
ancestri
educ
level
household
incom
percent
predict
forc
expiratori
volum
one
second
asthma
durat
current
smoke
statu
passiv
smoke
exposur
allerg
sensit
defin
allergenspecif
ige
valu
baselin
corticosteroid
use
composit
outcom
asthma
exacerb
includ
oral
corticosteroid
use
asthmarel
emerg
room
visit
asthmarel
hospit
addit
genet
model
code
minor
allel
domin
model
code
ag
recess
model
code
gg
timetoev
analys
analyz
cox
proport
hazard
regress
model
rate
event
analys
analyz
neg
binomi
regress
model
j
allergi
clin
immunol
author
manuscript
avail
pmc
octob
